US Stock MarketDetailed Quotes

CYTH Cyclo Therapeutics

Watchlist
  • 1.260
  • -0.030-2.33%
Close Apr 26 16:00 ET
  • 1.360
  • +0.100+7.94%
Pre 08:00 ET
36.18MMarket Cap-1024P/E (TTM)

About Cyclo Therapeutics Company

Cyclo Therapeutics, Inc. engages in the development of cyclodextrin-based biopharmaceuticals for the treatment of disease. Its product pipeline include Trappsol Cyclo, which treats Neimann-Pick Type C disease and Alzheimer's disease. The company was founded by Charles E. Rick Strattan on August 9, 1990 and is headquartered in Gainesville, FL.

Company Profile

SymbolCYTH
Company NameCyclo Therapeutics
Listing DateDec 9, 2020
Founded1990
CEOMr. N. Scott Fine
MarketNASDAQ
Employees8
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address6714 NW 16th Street,Suite B
CityGainesville
ProvinceFlorida
CountryUnited States of America
Zip Code32653
Phone1-386-418-8060
Websitehttp://www.cyclotherapeutics.com

Company Executives

  • Name
  • Position
  • Salary
  • N. Scott Fine
  • Director and Chief Executive Officer
  • 1.06M
  • Dr. Jeffrey L. Tate, PhD
  • Director and Chief Operating Officer
  • 218.19K
  • Michael Lisjak
  • Chief Regulatory Officer and Senior Vice President, Business Development
  • 582.70K
  • Joshua M. Fine
  • Chief Financial Officer, Principal Accounting Officer and Secretary
  • 586.18K
  • F. Patrick Ostronic
  • Vice Chairman of the Board
  • 55.00K
  • Markus W. Sieger
  • Chairman of the Board
  • 88.50K
  • C.E. Rick Strattan
  • Independent Director
  • 44.00K
  • William S. Shanahan
  • Independent Director
  • 53.50K
  • Dr. Vivien Wong, PhD
  • Independent Director
  • --
  • Dr. Randall M. Toig
  • Independent Director
  • 47.50K
  • Shawn Cross
  • Independent Director
  • --
  • William Conkling
  • Independent Director
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg